ePrints

Early Versus Delayed Invasive Management of Female Patients with Non-ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis

Lookup NU author(s): Dr Greg Mills, Dr Chris Kotanidis, Professor Vijay KunadianORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2025 American Heart Association, Inc.BACKGROUND: Female patients are at greater risk of adverse events following non-ST-elevation acute coronary syndrome but less frequently receive guideline-recommended coronary angiography and revascularization. Routine invasive management benefits high-risk patients, but evidence informing the optimal timing of angiography specifically in female patients is lacking. METHODS: Medline, Web of Science, and Scopus were searched up to November 2023. Randomized controlled trials investigating early versus delayed timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome were included. Individual patient data from female patients were extracted. The primary end point was a composite of all-cause mortality or myocardial infarction at 6 months. We performed a 1-stage individual patient data meta-analysis using random-effects Cox models. RESULTS: Six trials contributed individual patient data from 2257 female patients. Median time to coronary angiography was 5 hours in the early invasive group (n=1141) and 49 hours in the delayed invasive group (n=1116). Overall, there was no significant reduction in the risk of the primary end point in the early invasive group compared with the delayed group (hazard ratio, 0.79 [95% CI, 0.60-1.06]; P=0.12). Early invasive management was associated with a reduction in recurrent ischemia (hazard ratio, 0.60 [95% CI, 0.39-0.94]; P=0.025). In the prespecified subgroup analysis, high-risk female patients with Global Registry of Acute Coronary Events score >140 receiving early invasive management experienced a significantly reduced hazard for all-cause mortality or myocardial infarction at 6 months (hazard ratio, 0.65 [95% CI, 0.45-0.94]; P=0.021; Pinteraction=0.035). Similar benefits were observed for female patients with elevated cardiac biomarkers. CONCLUSIONS: Early invasive management in female patients with non-ST-elevation acute coronary syndrome, compared with delayed invasive management, was not associated with a significant reduction in the hazard for the primary end point. In prespecified subgroup analysis, high-risk female patients as assessed with Global Registry of Acute Coronary Events score >140 or elevated cardiac biomarkers experienced significant reductions in all-cause mortality or myocardial infarction at 6 months following early invasive management.

Publication metadata

Author(s): Mills GB, Kotanidis CP, Mehta S, Tiong D, Badings EA, Engstrom T, Van 'T Hof AWJ, Hofsten D, Holmvang L, Jobs A, Kober L, Milasinovic D, Milosevic A, Stankovic G, Thiele H, Mehran R, Kunadian V

Publication type: Article

Publication status: Published

Journal: Circulation: Cardiovascular Interventions

Year: 2025

Volume: 18

Issue: 3

Print publication date: 01/03/2025

Online publication date: 04/03/2025

Acceptance date: 19/12/2024

ISSN (print): 1941-7640

ISSN (electronic): 1941-7632

Publisher: Lippincott Williams and Wilkins

URL: https://doi.org/10.1161/CIRCINTERVENTIONS.124.014763

DOI: 10.1161/CIRCINTERVENTIONS.124.014763

PubMed id: 40035144

Altmetrics

Share